1 Small-Cap Stock to Add to Your Portfolio This Week and 1 to Sell

NASDAQ: CSWI | CSW Industrials, Inc. News, Ratings, and Charts

CSWI – With inflation showing signs of cooling down, the Fed will likely relax its aggressive monetary policy. Moreover, many are hopeful that the economy might witness a soft landing. While we believe investors should buy fundamentally sound small-cap stock CSW Industrials (CSWI), WeWork (WE) might be best avoided considering the market uncertainties. Read on….

With inflation coming in lower-than-expected for October, the market widely expects a 50-bps rate hike in December, a shift away from a 0.75% rate hike campaign. A majority of Fed officials also believe that a slowdown in the current pace of interest rate hikes would be appropriate soon. However, despite slowing rate hikes, interest rates need to rise higher than forecasts until they reach a “sufficiently restrictive” level.

Moreover, analysts projecting that U.S. fourth-quarter earnings will decline for the first time in two years, contracting business activities and a cooling labor market are all hinting towards a weakening economic momentum.

Although according to strategists at Goldman Sachs Group Inc. and Deutsche Bank, stock markets don’t yet reflect the risk of a U.S. recession. Many still believe the Federal Reserve can pull off a soft landing for the U.S. economy.

While we believe investors should consider buying quality small-cap stock CSW Industrials, Inc. (CSWI), WeWork Inc. (WE) might be best avoided, given the company’s bleak fundamental positioning.

Stock to Buy:

CSW Industrials, Inc. (CSWI)

CSWI operates as a diversified industrial company in the United States and internationally through three segments- Contractor Solutions; Engineered Building Solutions; and Specialized Reliability Solutions. The company has a market cap of $1.80 billion.

On October 14, CSWI declared a quarterly dividend of $0.17 per common share, payable to shareholders on November 14. CSWI pays a $0.68 per share dividend annually, which translates to a 0.58% yield on the current price. Its dividend payouts have grown at a CAGR of 34.7% over the past three years.

CSWI’s total revenues increased 23% year-over-year to $191.20 million in the second quarter ended September 30, 2022. The company’s net income increased 34% year-over-year to $24.30 million. Its EBITDA increased 29% year-over-year to $43.90 million, while its EPS rose 37% year-over-year to $1.57.

Street EPS estimate of $0.75 for the third fiscal quarter ending December 2022 reflects a rise of 43.3% year-over-year. Likewise, its revenue estimate of $165.70 million for the same quarter indicates an improvement of 21.6% from the prior-year quarter. Additionally, CSWI has topped consensus EPS estimates in three of the trailing four quarters.

CSWI’s forward P/E multiple of 21.02 is 15.5% higher than the industry average of 18.21. However, in terms of its forward non-GAAP PEG, the stock is trading at 1.45x, 2.3% lower than the industry average of 1.48x.

CSWI’s stock has gained 9.5% over the past six months, closing its last trading session at $118.15.

CSWI’s POWR Ratings reflect this promising outlook. The company has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

CSWI also has a B grade for Quality. It is ranked #21 out of 87 stocks in the A-rated Chemicals industry.

To see the additional POWR Ratings for CSWI (Growth, Value, Momentum, Stability, and Sentiment), click here.

Stock to Avoid:

WeWork Inc. (WE)

WE provide flexible workspace solutions to individuals and organizations worldwide. It delivers technology-driven turnkey solutions, flexible spaces, and community experiences. Its product offerings include Core space-as-a-service, WeWork On Demand, WeWork All Access, and WeWork Workplace. It has a market cap of $2.18 billion.

For the nine months ended September 30, WE’s net cash provided by financing activities decreased 71.3% year-over-year to $407 million. Its cash, cash equivalents, and restricted cash at the end of the period came in at $467 million, down 4.5% from the prior-year period.

Moreover, its total current assets for the period ended September 30, 2022, came in at $866 million compared to $1.47 billion for the period ended December 31, 2021.

WE’s EPS is expected to come in at a negative $0.49 for the fiscal fourth quarter ending December 2022. Its EPS is also expected to remain negative for the year ending December 2023.

Over the past year, the stock has lost 69.8% to close the last trading session at $2.71. It has declined 64.1% over the past six months.

WE’s poor prospects are reflected in its POWR Ratings. It has an overall F rating, equating to a Strong Sell in our proprietary rating system.

WE also have an F grade for Stability, Sentiment, and Quality and a D for Value. In the F-rated Real Estate Services industry, it is ranked 41 among 42 stocks.

Click here to access the additional POWR Ratings for Momentum and Growth for WE.


CSWI shares were trading at $119.53 per share on Tuesday afternoon, up $1.38 (+1.17%). Year-to-date, CSWI has declined -0.53%, versus a -16.02% rise in the benchmark S&P 500 index during the same period.


About the Author: Komal Bhattar


Komal's passion for the stock market and financial analysis led her to pursue investment research as a career. Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CSWIGet RatingGet RatingGet Rating
WEGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Why Its Time to Buy Small Cap Stocks

The S&P 500 (SPY) is making new record highs, but oddly small caps are heading lower in October. Why is that? And why does 44 year investment veteran say that now is the perfect time to buy up small caps for a big rally ahead? Read on for more...

3 Biotech Stocks With Huge Upside Based on Analyst Price Targets

The biotech sector’s long-term growth is fueled by strong government support, increasing funding and M&A activities, and rapid AI adoption. Therefore, quality biotech stocks Royalty Pharma (RPRX), BioMarin Pharmaceutical (BMRN), and Biogen (BIIB) with major upside could be ideal additions to your portfolio. Keep reading...

3 Tech Stocks Under $55 That Analysts Love

The technology industry is experiencing unprecedented expansion owing to the growing demand for generative AI, IT investment, and government support. Thus, it could be wise to invest in fundamentally sound tech stocks such as Pure Storage (PSTG), Flex (FLEX), and Informatica (INFA), which are currently trading under $55. Read on...

3 Consumer Discretionary Stocks to Watch for Holiday Gains

The consumer discretionary sector is poised for significant growth, driven by changing consumer behaviors, rising incomes, and increasing demands for entertainment, apparel, and leisure, particularly during the holiday season. Therefore, investors could consider watching consumer discretionary stocks: Amazon.com (AMZN), The Home Depot (HD), and Target (TGT) for potential holiday gains. Keep reading...

October Stock Market: More Trick Than Treat?

The S&P 500 (SPY) has been in the plus column for 5 straight months. Investment pro Steve Reitmeister shares why that party ends in October and how to prepare for resumption of the bull market in November and beyond. Read below for full story...

Read More Stories

More CSW Industrials, Inc. (CSWI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CSWI News